Sentences with phrase «drug prices»

Shares have been under pressure on drug pricing headlines but should benefit from stronger revenue and expectations of 5.9 % earnings growth this year.

The debate over high drug prices has been a red hot topic here and inspired a lot of anger and legislative threats, especially in the midst of the 2016 election cycle.

The poster boy for prescription drug price increases was arrested on securities fraud charges this week.

Its efforts to lower drug prices likely won't change much, and it probably knows that.

Another drug maker says it will voluntarily limit drug price hikes.

It issued six recommendations to ensure alignment of drug prices with their value, promote use of high - value drugs, and support innovation in cancer drug development.

Recent generic drug price increases have made us concerned and caused us to take positive action to address an opportunity to help a needy patient population.

In addition, researchers found low market competition levels had a more pronounced correlation with drug prices in lower - priced generic drugs compared with their higher - priced counterparts.

Although increases in generic drug prices are thought to be the result of insufficient competition, no study has examined this relationship.

I think that type of talk is mostly political rhetoric rather than something that will lead to actual legislation to control drug prices.

This is a hefty price tag yet may be necessary to compete in the increasingly competitive healthcare space in the face of drug pricing pressures.

The company is still facing federal investigations regarding its business and drug pricing practices.

And after announcing a «social contract» to keep drug price hikes below 10 percent a year, his company raised a slew of prices by 9.5 percent.

And regulate drug prices directly, as does every other country.

As drug patents begin to roll off and scrutiny around drug prices increased over the summer, many pharmaceutical company's struggled.

We investigated whether novelty of medications or their relative benefits affected drug pricing.

Rising insurance premiums, surprise medical bills, unfair drug price hikes — if you read the headlines, our collective anxiety over health costs is well - founded.

Each have come into question recently as prescription drug prices continue to rise.

The data suggest that reference pricing may be one instrument for influencing drug choices by patients and drug prices paid by employers and insurers.

And that started my efforts with regard to drug pricing trying to figure out exactly why that was happening.

I'm sure they'll understand... especially when monthly drug prices reach into the tens of thousands.

May 11, 2018 • The 39 - page drug price plan includes an array of ideas that the administration will consider, but it's unclear which ones will be implemented.

Now you can have access to a drug discount card that can save you money so you may never have to pay retail prescription drug prices again!

Life science companies are preparing themselves for continued regulatory uncertainty during 2017, as drug pricing remains a hot - button issue and regulations evolve to meet new healthcare reforms.

What sparked your interest in focusing on drug pricing?

But anger at high drug prices isn't going away.

And these lobbying budgets are increasing, with more policymakers turning their attention to the issue of drug pricing.

Drug pricing in the developed world is part of the bigger problem of rising healthcare costs.

Like a health insurance network, prescription discount cards have a network of participating partners that allow them to negotiate lower prescription drug prices.

And by keeping drug prices at their current levels, pharmaceutical companies also preserve their profit margins, while maintaining the flexibility to, yes, raise prices more moderately later on.

This is a bold and hefty price tag to pay yet may be necessary to compete in the increasingly competitive healthcare space in the face of drug pricing pressures.

Cigna's deal with Express Scripts will combine a health insurer with a pharmacy benefit manager, which negotiates drug prices with manufacturers and administers prescription drug programs on behalf of health insurers, self - insured companies and government agencies.

JPMorgan health care expert Lisa Gill shared her thoughts on the hotly - followed drug pricing debate as well as potential stock picks.

Among the detractors is Assemblyman John T. McDonald (D - Cohoes), a practicing pharmacist, who says there is no way to prevent pharmaceutical companies from raising drug prices.

A bit later, Trump detoured into an portion of the speech on the pharmaceutical industry, declaring the «injustice» of high U.S. drug prices as one of his «top priorities for the year.»

The report eased concerns about the company's ability to withstand fallout from drug pricing pressures that have been a headwind for the industry.

But after Frazier's announcement this morning, the president shot back with an angry tweet: «Now that Ken Frazier of Merck Pharma has resigned from President's Manufacturing Council, he will have more time to LOWER RIPOFF DRUG PRICES!»

Drug maker Mylan said it will offer a generic version of the life - saving allergy treatment EpiPen for half the list price of the brand - name treatment after it became the center of a national controversy over skyrocketing drug prices.

Express Scripts argued that Meridian's projections had failed to account for rising drug prices.

Spicer's comments during a press briefing predictably put a damper on biotech stocks — but it wasn't nearly the plunge the Trump administration's other statements about drug price regulations have wrought.

«They're running scared,» said Michael Weinstein, president of the AIDS Healthcare Foundation, the main backer of Prop 61, also known as «the California Drug Price Relief Act.»

But her underlying point isn't totally invalid — the furor over drug price hikes like Mylan's is forcing legislators and private companies alike to finally confront the issue head - on, and highlighting just how difficult the disparate and largely opaque American medical financing system makes it to address these problems in a serious way.

He teamed with hedge fund manager Kyle Bass to challenge the patents of pharmaceutical companies with high drug prices while shorting their stocks.

Since taking office, President Trump has talked tough about bringing drug prices down.

However analysts point to a bounce in Teva's shares over the past four months and a slowing in the rate of decline of U.S. generic drug prices as bright spots.

The biggest risk here is dramatic changes to the pricing structure on US drug prices with yesterday's announced partnership between Amazon, Berkshire and JPMorgan to change health care as evidence of change to come in the US.

Congressional Democrats introduce tough drug pricing bills.

In the wake of the 2016 Epipen and Daraprim drug pricing scandals, and as overall prices continue to climb, investors have grown frustrated by a lack of transparency on the part of the industry and believe a stronger message needs to be sent.